Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A

Antimicrobial Agents and Chemotherapy
C M ParryStephen Baker

Abstract

Azithromycin is an effective treatment for uncomplicated infections with Salmonella enterica serovar Typhi and serovar Paratyphi A (enteric fever), but there are no clinically validated MIC and disk zone size interpretative guidelines. We studied individual patient data from three randomized controlled trials (RCTs) of antimicrobial treatment in enteric fever in Vietnam, with azithromycin used in one treatment arm, to determine the relationship between azithromycin treatment response and the azithromycin MIC of the infecting isolate. We additionally compared the azithromycin MIC and the disk susceptibility zone sizes of 1,640 S. Typhi and S. Paratyphi A clinical isolates collected from seven Asian countries. In the RCTs, 214 patients who were treated with azithromycin at a dose of 10 to 20 mg/ml for 5 to 7 days were analyzed. Treatment was successful in 195 of 214 (91%) patients, with no significant difference in response (cure rate, fever clearance time) with MICs ranging from 4 to 16 μg/ml. The proportion of Asian enteric fever isolates with an MIC of ≤ 16 μg/ml was 1,452/1,460 (99.5%; 95% confidence interval [CI], 98.9 to 99.7) for S. Typhi and 207/240 (86.3%; 95% CI, 81.2 to 90.3) (P < 0.001) for S. Paratyphi A. A zone size...Continue Reading

References

Jan 1, 1990·The Journal of Antimicrobial Chemotherapy·G FouldsR B Johnson
Dec 1, 1974·The Journal of Infectious Diseases·C M Metzler, R M DeHaan
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·R M RakitaB E Murray
Jun 1, 1993·The Journal of Antimicrobial Chemotherapy·G PanteixM Perrin-Fayolle
Sep 3, 1999·The Journal of Antimicrobial Chemotherapy·T ButlerR B Johnson
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R W FrenckM Morsy
Sep 28, 2001·International Journal of Antimicrobial Agents·F Van Bambeke, P M Tulkens
Mar 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert W FrenckCharles Knirsch
Apr 2, 2004·The Journal of Antimicrobial Chemotherapy·N A C PotzD M Livermore
Jun 14, 2008·Journal of Clinical Microbiology·Nashwan Al NaiemiPaul H Savelkoul
Oct 29, 2009·Emerging Infectious Diseases·Minh Chau Phuc NguyenAnnie Canu
Apr 23, 2010·Emerging Infectious Diseases·Karen H KeddyStephen Oliver
May 26, 2010·Antimicrobial Agents and Chemotherapy·Marianne GunellAntti J Hakanen
Oct 15, 2010·Journal of Clinical Microbiology·Aoife MolloyM Estee Torok
Jun 22, 2011·Antimicrobial Agents and Chemotherapy·Maria Sjölund-KarlssonJean M Whichard
Jul 5, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T Butler
Mar 1, 2012·Indian Journal of Medical Microbiology·S RaiT N Dhole
Mar 25, 2014·Emerging Infectious Diseases·Robert-Jan HassingPerry J J van Genderen

❮ Previous
Next ❯

Citations

Dec 18, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Ingeborg LedererDaniela Schmid
Apr 17, 2016·Vaccine·Laura B MartinM Imran Khan
Aug 6, 2015·Journal of the Royal Army Medical Corps·Lucy G OsborneM S Bailey
Aug 16, 2016·Indian Journal of Medical Microbiology·S ChatterjeeC Mukhopadhyay
Aug 9, 2016·Tropical Medicine & International Health : TM & IH·S DivyashreeP Rupali
Dec 3, 2016·Journal of Medical Microbiology·Richa Misra, Kashi Nath Prasad
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Corinne N ThompsonStephen Baker
Nov 30, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Abi ManeshPriscilla Rupali
Nov 28, 2017·PLoS Neglected Tropical Diseases·Raphaël M ZellwegerAbhilasha Karkey
Jul 27, 2018·The American Journal of Tropical Medicine and Hygiene·Karen H KeddyFrew G Benson
May 28, 2020·The American Journal of Tropical Medicine and Hygiene·Farhana Khanam And The Strataa Study Team
Mar 22, 2018·MBio·Myron M Levine, Raphael Simon
Feb 2, 2021·PLoS Neglected Tropical Diseases·Jessica Z Kubicek-SutherlandNorman A Doggett
Feb 8, 2021·Journal of Travel Medicine·Abi ManeshPriscilla Rupali
Mar 21, 2021·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·María José González-Abad, Mercedes Alonso Sanz
May 1, 2021·Pathogens·Durga P NeupaneJeongmin Song
Jul 6, 2021·JAC-antimicrobial Resistance·Pham Thanh DuyAbhilasha Karkey
Sep 18, 2021·The Journal of Antimicrobial Chemotherapy·Elli MylonaStephen Baker

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
PCRs

Software Mentioned

SPSS

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.